Novo Nordisk A/S (NVO) stock

Last close 40.70 USD (Nov 10, 2026), on the day −1.6 %.

• Sector: Healthcare, Drug Manufacturers - General.
• Market cap: 182.5B USD.
• P/E: 10.4. Forward P/E: 12.2.
• Dividend yield: 4.34 %.
• Over 52 weeks: low 35.29 USD, high 63.98 USD, price change −11.4 %.
• Analysts' average 12-month target from Yahoo Finance: 46 USD (12 analysts). Not our estimate.

Earnings

• Feb 3, 2027: EPS not yet, estimate 4.87
• Nov 4, 2026: EPS 5.79, estimate 4.62
• Aug 4, 2026: EPS 6.18, estimate 4.98
• May 5, 2026: EPS 6.63, estimate 6.96
• Feb 3, 2026: EPS 6.04, estimate 5.90
• Nov 5, 2025: EPS 4.50, estimate 4.24

Which large investors hold it

• Tom Gayner – 0.8 % of the portfolio
• Dodge & Cox – 0.5 % of the portfolio

In baskets

• Pharma

Similar companies: ABBV · AMGN · AZN · BIIB · BMY · GILD · GSK · JNJ · LLY · MRK · NOVN.SW · PFE